Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig.7.B
Gur M et al. (2022)
|
Xla Wt + aldh1a2 CRISPR
NF10.25 (RT-PCR)
|
|
|
|
Fig.7.C
Gur M et al. (2022)
|
Xla Wt + aldh1a2 CRISPR
NF12 (RT-PCR)
|
|
|
|
Fig.4.I
Gur M et al. (2022)
|
Xla Wt + bmp4
NF11 (RT-PCR)
|
|
|
|
Fig.4.I
Gur M et al. (2022)
|
Xla Wt + bmp4
NF13 (RT-PCR)
|
|
|
|
Fig.7.A
Gur M et al. (2022)
|
Xla Wt + Retinoic acid
NF12 (RT-PCR)
|
|
|
|
Fig.7.C
Gur M et al. (2022)
|
Xla Wt + Retinoic acid
NF12 (RT-PCR)
|
|
|
|
Fig.4.H
Gur M et al. (2022)
|
Xla Wt + wnt8a
NF10.25 (RT-PCR)
|
|
|
|
Fig.4.H
Gur M et al. (2022)
|
Xla Wt + wnt8a
NF11 (RT-PCR)
|
|
|
|
Fig.4.H
Gur M et al. (2022)
|
Xla Wt + wnt8a
NF13 (RT-PCR)
|
|
|
|
fig.4.d
Rankin SA et al. (2012)
|
Xtr Wt + BMS493
NF35/36 (in situ hybridization)
|
|
|